Balyasny Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-605,294
| Closed | -$23.3M | – | 2346 |
|
|
2023
Q2 | $23.3M | Buy |
+605,294
| New | +$23.3M | 0.05% | 395 |
|
|
2023
Q1 | – | Sell |
-90,140
| Closed | -$2.36M | – | 2797 |
|
|
2022
Q4 | $2.36M | Sell |
90,140
-190,147
| -68% | -$4.98M | 0.01% | 998 |
|
|
2022
Q3 | $5.51M | Buy |
+280,287
| New | +$5.51M | 0.02% | 720 |
|
|
2018
Q4 | – | Sell |
-16,193
| Closed | -$595K | – | 1646 |
|
|
2018
Q3 | $595K | Buy |
16,193
+13,616
| +528% | +$500K | ﹤0.01% | 1112 |
|
|
2018
Q2 | $90K | Buy |
+2,577
| New | +$90K | ﹤0.01% | 1535 |
|
|
2017
Q2 | – | Sell |
-15,720
| Closed | -$845K | – | 1574 |
|
|
2017
Q1 | $845K | Buy |
+15,720
| New | +$845K | ﹤0.01% | 986 |
|